Catalyst Wire Dossier Catalyst Wire Dossier

Eluxadoline (Viberzi)

eluxadoline · Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eluxadoline (Viberzi), covering 2019-02-15 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use [Phase 4]

See pricing